Utility of ctDNA in Early Switch of First-line mFOLFIRINOX in Metastatic Pancreatic Ductal Adenocarcinoma
Clinical trial NCT07096362 · RECRUITING
Trial details
- NCT number
- NCT07096362
- Sponsor
- University of Miami
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-09
- Primary completion
- 2030-09-30
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.